Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use AFREZZA ® safely and effectively. See full prescribing information for AFREZZA. AFREZZA ® (insulin human) inhalation powder, for oral inhalation use Initial U.S. Approval: 2014
Medication labelWhy this: Advisory · dailymed-prescription
AFREZZA ® is indicated to improve glycemic control in adult and pediatric patients 6 years of age and older with diabetes mellitus. Limitations of Use: AFREZZA is not recommended for the treatment of diabetic ketoacidosis (DKA) [see Warnings and Precautions ( 5.6)] . The safety and effectiveness of AFREZZA in patients who smoke have not been established. The use of AFREZZA is not recommended in patients who smoke or who have recently stopped smoking [see Warnings and Precautions ( 5.5)].
- generic_name
- insulin human
- product_names
- INSULIN HUMAN
- ndc
- 47918-874, 47918-878, 47918-891, 47918-880, 47918-898, 47918-902, 47918-904, 47918-874-90, 47918-878-90, 47918-891-90, 47918-880-18, 47918-898-18, 47918-902-18, 47918-904-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en